ArticleProtein science : a publication of the Protein Society2026
Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
FAD/NAD(P)H-dependent dehydrogenases form a structurally conserved family of redox enzymes that participate in essential metabolic processes across parasites and higher organisms. Among them, trypanothione reductase (TR) is a key component of the redox metabolism of Leishmania species and represents an attractive target for antileishmanial drug development. However, because several flavoproteins share similar folds and cofactor-binding architectures, the selectivity of TR inhibitors remains a critical issue during early drug discovery. To explore this aspect, we investigated the structural landscape of FAD/NAD(P)H-dependent dehydrogenases in Leishmania infantum by integrating sequence analysis, structural modeling, docking simulations, and in vitro biochemical validation. Reciprocal sequence searches revealed 11 parasite flavoproteins structurally related to TR, including a dihydrolipoamide dehydrogenase (DLD)-like protein, a type II NADH dehydrogenase (NDH2)-like protein, and a dienoyl-CoA reductase (deCoAR)-like protein. Comparative docking analyses across parasite and mammalian homologs allowed us to examine potential cross-reactivity patterns among these enzymes. Enzymatic assays performed on recombinant L. infantum TR (LiTR) and Caldalkalibacillus thermarum NDH2 (CtNDH2) confirmed that selected ligands can exert enzyme-dependent effects. In particular, auranofin and, to a lesser extent, nitrofurazone inhibited LiTR, whereas a terpyridine-Pt-derived compound strongly inhibited LiTR while stimulating CtNDH2 activity. Overall, the results illustrate how structurally related flavoproteins may accommodate common ligands while responding with distinct catalytic outcomes. The integrated computational and biochemical workflow presented here provides a practical framework for assessing ligand selectivity within the FAD/NAD(P)H-dependent dehydrogenase family and may support the development of selective modulators targeting parasite redox metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.